- Report
- February 2022
- 40 Pages
Ireland
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Japan
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Russia
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
South Korea
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
United States
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Vietnam
From €1365EUR$1,500USD£1,160GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- May 2023
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2021
- 1112 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Report
- October 2023
- 272 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- March 2022
- 256 Pages
Global
From €2271EUR$2,496USD£1,929GBP
€3245EUR$3,565USD£2,756GBP
Isothermal Nucleic Acid Amplification Technology (INAAT) is a molecular diagnostic technique used to detect and quantify nucleic acid sequences. It is a rapid, cost-effective, and highly sensitive method for the detection of infectious agents. INAAT is based on the amplification of nucleic acid sequences using isothermal amplification techniques such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA). These techniques are used to detect and quantify nucleic acid sequences from a variety of sources, including viruses, bacteria, and fungi.
INAAT is used in a variety of clinical applications, including the diagnosis of infectious diseases, the detection of genetic mutations, and the identification of cancer biomarkers. It is also used in food safety testing, environmental monitoring, and forensic analysis. INAAT has become increasingly popular in recent years due to its rapid turnaround time, cost-effectiveness, and high sensitivity.
Some of the major companies in the INAAT market include Abbott, Becton Dickinson, Cepheid, Hologic, Qiagen, Roche, and Thermo Fisher Scientific. Show Less Read more